Clinical Trial Update: GVAX vs. Placebo for MDS/AML After Allo HSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating GVAX versus placebo for myelodysplastic syndrome and acute myeloid leukemia after allogeneic stem cell transplantation has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• GVAX

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2022-03-18